AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Bupivacaine Hydrochloride USP
4 registrations across 3 African markets— 4 active
Markets with Bupivacaine Hydrochloride USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BUPISTAR INJECTION Injection | 🇰🇪Kenya | GOODMED PHARMACY LTD | active | Dec 2030 |
| Bupitroy 0.5% injection Solution for Injection | 🇿🇲Zambia | Troikaa Pharmaceuticals Ltd | active | Sept 2029 |
| BUPITROY HEAVY Solution for injection | 🇷🇼Rwanda | Troikaa Pharmaceuticals Ltd | active | Aug 2029 |
| SENSOCAIN Solution For Injection | 🇰🇪Kenya | Brookes Pharma Private Ltd | active | Mar 2029 |
Bupivacaine Hydrochloride USP in Africa — Regulatory Overview
Bupivacaine Hydrochloride USP is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 4 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.